FDA授权销售20种ZYN尼古丁口含袋产品 智通财经APP获悉，天风证券发布研报称，根据欧睿国际数据显示(数据为尼古丁袋口含烟数据)，2024 年全球口含烟市场规模为112.32亿美元，同比+57.57%，预计2028年达到251.48亿美元，2024- 2028CAGR为22.32%。北美、欧洲口含烟市场目前增速依然保持较高水平，目前仍有较大的市场空间； 亚洲和非洲口含烟市场目前处于早期阶段，随着口含烟市场的进一步发展，新兴市场的市场潜力有望快 速兑现。此外，FDA对于口含烟水果味的审批，有望成为口含烟市场的催化剂，进一步提升市场的增 速，抬高整个市场的空间上限。 天风证券主要观点如下： 口含烟零售市场集中度高，菲莫国际、英美烟草、奥驰亚口含烟业务表现亮眼 根据欧睿国际数据显示(数据为尼古丁袋口含烟数据)，2024年全球口含烟市场规模为112.32亿美元，同 比+57.57%，预计2028年达到251.48亿美元，2024-2028CAGR为22.32%，其中北美市场2024年口含烟市 场规模为87.75亿美元，同比+58.30%，预计2028年达到194.49亿美元，2024-2028CAGR为22.01 ...

Glo Hilo 日本销售反馈积极，核心供应商思摩尔国际成长 空间广阔 20250824 摘要 思摩尔国际的新产品于 2025 年 6 月 9 日在日本宫城县首次发布。宫城县是英 美烟草上一代产品 Hyper Glow 最早推广的地区，同时也是 HMB 渗透率最高 的地区之一，达到 56%。思摩尔选择该地作为首发地具有代表性，因为高渗透 率意味着消费者对该品类较为熟悉，有助于加快新产品教育和推广。在上市初 期，通过广告宣传和各种推广活动逐步提高知名度，目前其产品已在仙台市的 大多数便利店中陈列，并且位置较为显眼，如全家、罗森和 new days 等主流 便利店。 日本各主要品牌的新型烟草产品有哪些差异化特点？ 日本主要品牌的新型烟草产品在设计理念上有明显差异化。例如，日本烟草公 司的 Pro 系列采用低温加热（约 280 度），符合当地消费者偏好清淡口味、低 雾量卷烟习惯；菲莫国际的 IQOS 则处于中间档次；而英美烟草与思摩尔合作 推出的 GLO Helo 系列则定位高温、大雾量、重口味。这些差异化设计使得各 品牌能够针对不同消费群体提供不同体验，从而避免直接竞争。 日本 HNB 市场渗透率全球领先，202 ...

Investment Rating - The report maintains an "Accumulate" rating for the industry, indicating a positive outlook for future performance [1]. Core Insights - Philip Morris International (PMI) reported Q2 2025 revenue of $10.1 billion, with an organic year-over-year growth of 6.8%. For the first half of 2025, revenue reached $19.4 billion, up 6.5% year-over-year. The revenue from smoke-free products was $4.2 billion, reflecting a 14.5% organic growth and accounting for 41% of total revenue [4][9]. - The Heat-Not-Burn (HNB) segment continues to grow, with Q2 HNB sales reaching 38.8 billion units, a year-over-year increase of 9.2%. Excluding channel inventory effects, the growth rate was 11.4%. As of Q2 2025, the number of HNB users reached 34 million, with Japan's HNB penetration rate increasing to 48% [4][10]. - British American Tobacco (BAT) reported H1 2025 revenue of £12.569 billion, a 1.8% increase year-over-year at constant exchange rates. The revenue from new tobacco products was £1.651 billion, up 2.4%, representing 18.2% of total revenue [4][10]. Summary by Sections Industry Trends - The global tobacco industry is approaching a market size of nearly $1 trillion, with new tobacco products growing at a faster pace and expected to capture more market share. Major players like PMI and BAT are increasing their focus on smoke-free products, particularly HNB [4][12]. Company Performance - PMI's Q2 2025 performance highlights include a 14.5% increase in smoke-free product revenue and a 100% increase in electronic vapor product sales. The company maintains a full-year sales growth forecast of 10-12% for HNB products [4][9]. - BAT's H1 2025 results show a mixed performance in new tobacco products, with HNB revenue growing modestly while electronic vapor products faced challenges due to regulatory issues [4][10]. Investment Recommendations - The report suggests monitoring companies linked to new tobacco products, such as Smoore International, a leading OEM for BAT's HNB products, and Yingqu Technology, the manufacturer for PMI's IQOS [4][12].

Investment Rating - Industry rating is maintained as "Outperform" [9] Core Insights - The report highlights that reduced-harm products and oral tobacco have become the core growth engines for British American Tobacco (BAT) and Philip Morris International (PMI) [1][3] - BAT's revenue for the first half of 2025 was £12.069 billion, a decrease of 2.2% year-on-year, but a 1.8% increase when excluding currency effects, primarily driven by recovery in the US market [1] - PMI reported a revenue of $19.4 billion for the first half of 2025, reflecting a year-on-year growth of 6.5% [3] Summary by Sections British American Tobacco (BAT) - BAT's operating profit for the first half of 2025 was £5.069 billion, a year-on-year increase of 19.1%, with an operating margin rising by 7.5 percentage points to 42.0% [1] - The diluted EPS for BAT was £2.036, up 1.6% year-on-year [1] - The number of consumers of BAT's reduced-harm products reached 30.5 million, an increase of 1.4 million year-on-year [2] - Modern oral products generated £470 million in revenue, a 38.1% increase year-on-year, with sales volume rising by 42.2% [2] Philip Morris International (PMI) - PMI's gross profit for the first half of 2025 was $13.1 billion, a 12.0% increase year-on-year [3] - The adjusted diluted EPS for PMI was $3.6, reflecting a year-on-year growth of 16.1% [3] - PMI's total shipment volume for the first half of 2025 was 387.9 billion units, a 2.5% increase year-on-year [4] - Reduced-harm product shipments reached 87.9 billion units, a 13.1% increase year-on-year, with 41.5 million consumers globally, an increase of 5 million [4] Regional Performance - In Japan, IQOS covered over 10 million legal-age consumers, with a shipment volume of 13.9 billion units in Q2 2025, a 3.2% increase year-on-year [6] - In the EU, IQOS shipments reached 6 billion units in Q2 2025, a 13.21% increase year-on-year [6] - In South Korea, IQOS shipments were 1.6 billion units in Q2 2025, a 12.8% increase year-on-year [6] Investment Opportunities - The report suggests focusing on the vaping supply chain, including companies like Smoore International and Yihua Healthcare, as well as the tobacco supply chain with companies like China Tobacco Hong Kong and China Boton [7]

Investment Rating - The investment rating for the company is "Positive" [2] Core Insights - The company reported a revenue of $10.14 billion for Q2 2025, representing a year-on-year increase of 7.1%, with a gross margin of 68.3%, up by 4.1 percentage points [2] - Revenue from new tobacco products reached $4.16 billion, showing a year-on-year growth of 15.2%, accounting for 41% of total revenue, with a gross margin of 69.0%, an increase of 4.6 percentage points [2] - The new tobacco segment is viewed as the company's second growth curve, with continuous expansion in product and regional matrices, now available in 97 markets globally, with a total user base of 41.5 million, an increase of 5 million year-on-year [2] - The core product, IQOS, achieved a shipment volume of 39.9 billion units in Q2, a year-on-year increase of 9.2%, with revenue exceeding $3 billion and a market share of 76% in the HNB market [2][3] - The company anticipates a decline of 2% in global cigarette sales for 2025, while maintaining a growth forecast of 12% to 14% for new tobacco products, with HNB growth expected at 10% to 12% [3] Summary by Sections Financial Performance - Q2 2025 revenue was $10.14 billion, up 7.1% year-on-year, with a gross margin of 68.3% [2] - New tobacco revenue was $4.16 billion, a 15.2% increase, with a gross margin of 69.0% [2] Product Performance - IQOS shipments reached 39.9 billion units, a 9.2% increase, with revenue over $3 billion [2][3] - The nicotine pouch segment saw a 23.8% increase in sales, driven by the ZYN brand in the U.S. [3] - VEEV sales doubled in Q2 2025, primarily due to European market contributions [3] Market Outlook - The company expects a 2% decline in cigarette sales for 2025, while new tobacco products are projected to grow by 12% to 14% [3] - The introduction of IQOS ILUMA in the U.S. is anticipated to be a significant change in the new tobacco industry [3]

Investment Rating - The industry investment rating is "Positive" [2] Core Viewpoints - The report emphasizes the current favorable conditions for export chain layout and the rebound of new consumption, suggesting a focus on bottom-cycle assets [2] - The paper highlights various sectors including paper manufacturing, new tobacco, exports, smart glasses, home furnishings, gold and jewelry, two-wheeled vehicles, pets, cross-border e-commerce, retail IP, and mother-baby products, each with specific growth opportunities and recommendations [2][3][4][5][6] Summary by Relevant Sections Paper Manufacturing - The report notes ongoing overseas supply disruptions and domestic efforts to combat "involution," which may drive the paper cycle upward. It suggests monitoring companies like Sun Paper and Xianhe Co. for potential profit recovery [2] New Tobacco - Philip Morris International reported Q2 revenue of $10.14 billion, a year-on-year increase of 7.1%, with new tobacco revenue up 15.2%. The report anticipates a 12%-14% growth in new tobacco shipments for the year [2] Exports - June export data showed a year-on-year increase of 7.0%, with furniture exports up 1.9%. The report suggests focusing on companies with robust overseas production capabilities due to ongoing tariff impacts [2] Smart Glasses - Alibaba's launch of the Quark AI glasses is expected to enhance the industry's influence, with anticipated sales growth driven by improved product capabilities [3] Home Furnishings - Despite industry pressures, companies like IYI Home are experiencing steady growth due to high customer repurchase rates. The report recommends focusing on brands that cater to young consumers [4] Gold and Jewelry - Chow Tai Fook's retail value decreased by 1.9% year-on-year, but the report suggests that the overall market may be nearing a recovery point [4] Two-Wheeled Vehicles - TaoTao's global manufacturing layout is accelerating, with significant production capacity in Vietnam and the U.S. expected to meet market demands [4] Pets - Yuanfei Pet's stock incentive plan targets revenue growth, with a focus on enhancing its overseas supply chain and developing proprietary brands [4] Cross-Border E-commerce - The report highlights ongoing uncertainties regarding tariffs, with leading sellers actively pursuing global expansion strategies [4] Retail IP - The report discusses the growth of Pop Mart and its strategies to enhance brand recognition and operational capabilities [4] Mother-Baby Products - The report notes that children's health care is becoming increasingly competitive, with companies like Kidswant leveraging technology for market advantage [5]

Core Viewpoint - The article reviews the development history of leading international tobacco companies in the context of intensifying global competition in heated not burned (HNB) products, summarizing successful experiences and projecting future trends [1][5]. Group 1: International Tobacco HNB Development Review - Philip Morris International (PMI) launched IQOS ILUMA in 2021, utilizing electromagnetic induction technology, achieving a compound annual growth rate (CAGR) of 41.4% in revenue from 2018 to 2024, with a projected shipment volume of 139.7 billion sticks in 2024 [3]. - Japan Tobacco introduced Ploom X in 2021, employing four-way airflow heating technology, with a projected shipment volume of 10.9 billion sticks in 2024 [3]. - British American Tobacco (BAT) anticipates a shipment volume of 20.9 billion sticks for its Glo series in 2024, with the Glo Hilo high-end heating platform set to launch in Japan in June 2025 after trials in Serbia [3]. Group 2: Insights from Stock Price Review of International Tobacco Leaders - Regulatory clarity significantly impacts business expansion and stock performance, with U.S. FDA approval timelines and European flavor bans affecting market dynamics [3]. - The pathway for HNB promotion is characterized by strong single products, trial feedback, global expansion, and profit enhancement, with market expectations, revenue growth, and performance realization driving capital market performance [3]. - Strong technology-driven single products are crucial for HNB market penetration, with specific market trial feedback shaping expectations and driving valuation increases [3]. Group 3: Financial Performance of Philip Morris International - PMI's revenue has shown consistent growth, with a CAGR of 4.5% from 2016 to 2024, leading among international tobacco companies, while net profit has fluctuated due to product mix and exchange rate impacts [7]. - The revenue from HNB products has grown at a CAGR of 45% from 2016 to 2024, with its share of total revenue increasing from 2.7% in 2016 to 37.8% in 2024, and HNB gross margins surpassing traditional cigarettes for the first time in 2024 [7][10]. Group 4: Financial Performance of Japan Tobacco - Japan Tobacco's traditional cigarette sales have remained stable, with HNB products driving rapid growth since 2022, particularly in the Japanese market where HNB sales are projected to reach approximately 9 billion sticks in 2024 [20][22]. - The Ploom X product has significantly contributed to revenue growth, with a projected 24.2% increase in sales volume and a 21.1% increase in revenue in 2024 [22]. Group 5: Financial Performance of British American Tobacco - BAT's traditional cigarette revenue is under pressure, with a projected decline in revenue and volume from 2019 to 2024 [33]. - New tobacco products, including HNB and oral nicotine products, are expected to take over growth from the declining e-cigarette segment, with a CAGR of 22% from 2019 to 2024 for new tobacco products [35].

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Viewpoints - Recent trial feedback for Glo Hilo in Sendai, Japan has been positive, indicating that improvements in HNB product experience and faster conversion of smokers will drive industry growth, benefiting the company through its partnership with British American Tobacco [2] - The price increase of Glo Hilo's cartridges reflects confidence in product strength, with the new cartridge priced at 580 JPY (approximately 4 USD), a more than 30% increase from the previous model [3] - British American Tobacco is expected to invest significantly in Hilo, aiming for new tobacco revenue to reach 50% by 2035, up from the current 13%, highlighting the importance of HNB products for the company's future [4] Summary by Sections Recent Catalysts and Core Viewpoints - Glo Hilo's trial in Japan has shown promising results, suggesting a potential acceleration in industry growth due to enhanced product experiences [2] - The price increase of Hilo cartridges indicates strong product confidence and potential for higher returns for the company [3] - British American Tobacco's commitment to HNB products is expected to increase, with significant resources allocated to Hilo [4] Market Dynamics - The HNB market is evolving, with improved product experiences leading to higher conversion rates among traditional smokers [8] - The competitive landscape is shifting, with major players like Philip Morris, Japan Tobacco, and British American Tobacco sharing market shares more evenly [9] Regulatory Environment and Business Potential - The company is poised to benefit from stricter regulations on vaping products in Europe and North America, which may lead to increased demand for compliant products [10] - The medical business segment is expected to gain importance, with significant investments in research and development for HNB and medical aerosol products [11] Financial Projections and Valuation - Revenue projections for 2025-2027 are estimated at 128.9 billion, 153.1 billion, and 183.5 billion, with year-on-year growth rates of 9%, 19%, and 20% respectively [12] - The company is expected to achieve net profits of 13.2 billion, 20.0 billion, and 27.3 billion for the same period, with corresponding growth rates of 2%, 51%, and 36% [12]

Group 1 - The report highlights that the global refined oil transportation market is expected to experience a recovery in 2025, with the company's quarterly performance anticipated to improve sequentially [3][5] - The company is the only refined oil transportation company listed in A-shares, and its profitability has significantly increased over the past three years, with expectations for continued high profitability in 2025 [2][3] - The global refinery relocation trend is expected to benefit the industry, leading to a potential recovery in dividend distribution and accelerated shareholder returns [4][5] Group 2 - The report on Steady Medical indicates that the company is expected to maintain its earnings forecast, with projected EPS for 2025-2027 being 1.77, 2.18, and 2.49 yuan respectively [6][7] - The cotton soft towel and sanitary napkin business of the company is expected to see significant revenue growth in 2024, attributed to strategic transformations in product, channel, and brand marketing [7][8] - The company is focusing on high-quality product positioning and expanding its online and offline channels, which is expected to enhance brand visibility and drive revenue growth [8][27] Group 3 - The durable consumer goods industry report emphasizes the successful path of IQOS, highlighting the importance of product strength, marketing, and channel synergy in establishing brand value [9][10] - The Japanese market for HNB products has reached a penetration rate of over 40%, with significant growth potential as traditional cigarette markets shrink [9][11] - The report suggests that the competitive landscape in the HNB market is evolving, with major brands actively participating in market cultivation, leading to accelerated industry expansion [9][10] Group 4 - The military industry report indicates that the ongoing geopolitical tensions are likely to drive long-term growth in the military sector, with increased defense spending expected [23][24] - Recent military agreements, such as the tank export deal between South Korea and Poland, highlight the strengthening of military cooperation and the potential for significant military sales contracts [25][26] - The report recommends various companies within the military sector, focusing on assembly, components, and systems, as the industry is poised for growth amid rising defense demands [26][27]

Group 1: PMI and HNB Market Insights - PMI's investor event highlighted that the share of vaporized e-cigarettes in IQOS's customer acquisition channels in Europe has increased to 20%, indicating a growing appeal of HNB products among vaporized cigarette consumers [1] - The proportion of IQOS users who also use Philip Morris's ZYN or VEEV products has doubled from 16% in Q1 2024 to 32% in Q1 2025, showcasing the increasing cross-utilization effect among different tobacco product categories [1] - HNB product penetration is expected to accelerate due to new product launches and improved user experiences, with current global penetration below 6% [2] Group 2: Product Development and Market Trends - The latest IQOS product iteration, Iluma i series, was released in March 2024, and significant technological advancements are anticipated in the next iteration expected in 2026 [2] - The company has upgraded its status from a secondary plastic component supplier to a primary supplier for complete devices and key heating components, which is expected to enhance revenue contributions [2] - The air purification and water purification markets are projected to grow significantly, with the U.S. air purifier market expected to rise from approximately $4.546 billion in 2024 to $6.82 billion by 2030, reflecting a CAGR of about 7.2% [3] Group 3: Diversification and Growth Opportunities - The automotive electronics sector is anticipated to maintain rapid growth, with a projected market size increase from CNY 614 million in 2024, representing a year-on-year growth of 19% [4] - The collaboration with Logitech has deepened, leading to increased revenue from gaming and video collaboration products, with gaming product revenue growing from $245 million in 2016 to $1.338 billion in 2024 [4] - The brain-computer interface sector is gaining traction, with successful collaborations and product sales to numerous educational and research institutions, which may contribute positively to future performance [6] Group 4: Financial Projections - The company is expected to achieve revenues of CNY 46.09 billion, CNY 57.51 billion, and CNY 67.59 billion for the years 2025 to 2027, reflecting year-on-year growth rates of 29.01%, 24.77%, and 17.52% respectively [7] - Net profits are projected to reach CNY 4.60 billion, CNY 6.41 billion, and CNY 8.34 billion for the same period, with significant growth rates of 82.86%, 39.41%, and 30.05% respectively [7]